| pubmed-article:11939924 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11939924 | lifeskim:mentions | umls-concept:C0022864 | lld:lifeskim |
| pubmed-article:11939924 | lifeskim:mentions | umls-concept:C0143993 | lld:lifeskim |
| pubmed-article:11939924 | lifeskim:mentions | umls-concept:C0073571 | lld:lifeskim |
| pubmed-article:11939924 | lifeskim:mentions | umls-concept:C0002769 | lld:lifeskim |
| pubmed-article:11939924 | lifeskim:mentions | umls-concept:C0439294 | lld:lifeskim |
| pubmed-article:11939924 | lifeskim:mentions | umls-concept:C1178443 | lld:lifeskim |
| pubmed-article:11939924 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11939924 | pubmed:dateCreated | 2002-4-9 | lld:pubmed |
| pubmed-article:11939924 | pubmed:abstractText | In recent studies, minimum local analgesic concentrations have been defined as 0.93 mg/mL for bupivacaine and 1.56 mg/mL for ropivacaine for epidural analgesia for the first stage of labour, resulting in an analgesic potency ratio of 1 : 0.6. In the current study we compared ropivacaine and bupivacaine in a PCEA system (combined with sufentanil) taking this potency ratio into account but administering drug doses providing sufficient analgesia for all stages of labour. | lld:pubmed |
| pubmed-article:11939924 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11939924 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11939924 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11939924 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11939924 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11939924 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11939924 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11939924 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11939924 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11939924 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11939924 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11939924 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:11939924 | pubmed:issn | 0001-5172 | lld:pubmed |
| pubmed-article:11939924 | pubmed:author | pubmed-author:SchwenderDD | lld:pubmed |
| pubmed-article:11939924 | pubmed:author | pubmed-author:SarafSS | lld:pubmed |
| pubmed-article:11939924 | pubmed:author | pubmed-author:ZwisslerBB | lld:pubmed |
| pubmed-article:11939924 | pubmed:author | pubmed-author:BernasconiHH | lld:pubmed |
| pubmed-article:11939924 | pubmed:author | pubmed-author:Hofmann-Kiefe... | lld:pubmed |
| pubmed-article:11939924 | pubmed:author | pubmed-author:BrederodeAA | lld:pubmed |
| pubmed-article:11939924 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11939924 | pubmed:volume | 46 | lld:pubmed |
| pubmed-article:11939924 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11939924 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11939924 | pubmed:pagination | 316-21 | lld:pubmed |
| pubmed-article:11939924 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11939924 | pubmed:meshHeading | pubmed-meshheading:11939924... | lld:pubmed |
| pubmed-article:11939924 | pubmed:meshHeading | pubmed-meshheading:11939924... | lld:pubmed |
| pubmed-article:11939924 | pubmed:meshHeading | pubmed-meshheading:11939924... | lld:pubmed |
| pubmed-article:11939924 | pubmed:meshHeading | pubmed-meshheading:11939924... | lld:pubmed |
| pubmed-article:11939924 | pubmed:meshHeading | pubmed-meshheading:11939924... | lld:pubmed |
| pubmed-article:11939924 | pubmed:meshHeading | pubmed-meshheading:11939924... | lld:pubmed |
| pubmed-article:11939924 | pubmed:meshHeading | pubmed-meshheading:11939924... | lld:pubmed |
| pubmed-article:11939924 | pubmed:meshHeading | pubmed-meshheading:11939924... | lld:pubmed |
| pubmed-article:11939924 | pubmed:meshHeading | pubmed-meshheading:11939924... | lld:pubmed |
| pubmed-article:11939924 | pubmed:meshHeading | pubmed-meshheading:11939924... | lld:pubmed |
| pubmed-article:11939924 | pubmed:meshHeading | pubmed-meshheading:11939924... | lld:pubmed |
| pubmed-article:11939924 | pubmed:meshHeading | pubmed-meshheading:11939924... | lld:pubmed |
| pubmed-article:11939924 | pubmed:meshHeading | pubmed-meshheading:11939924... | lld:pubmed |
| pubmed-article:11939924 | pubmed:meshHeading | pubmed-meshheading:11939924... | lld:pubmed |
| pubmed-article:11939924 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11939924 | pubmed:articleTitle | Ropivacaine 2 mg/mL vs. bupivacaine 1.25 mg/mL with sufentanil using patient-controlled epidural analgesia in labour. | lld:pubmed |
| pubmed-article:11939924 | pubmed:affiliation | Klinik für Anäesthesiologie der Ludwig-Maximilians-Universität München, Klinikum Innenstadt, Munich, Germany. | lld:pubmed |
| pubmed-article:11939924 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11939924 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11939924 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11939924 | lld:pubmed |
